Brief: Kineta Receives Notice Of Termination Of Exclusive Option,License Agreement From Genentech
30/12/2022 22:08
Dec 30 (Reuters) - Kineta Inc KA.O :
* KINETA-ON DEC 27,CO THROUGH UNIT,RECEIVED WRITTEN NOTICE
FROM
GENENTECH OF ITS TERMINATION OF EXCLUSIVE OPTION,LICENSE
AGREEMENT DATED APRIL 11, 2018
* KINETA - TERMINATION OF THE AGREEMENT DOES NOT AFFECT THE
DEVELOPMENT OF ANY OF THE COMPANY’S CORE ONCOLOGY PRODUCTS
Source: (https://bit.ly/3Gsigxy)
Further company coverage: KA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study